Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16.83	6.21	20.75	44.58	69.72	66.84
Short-Term Investments	17.88	34.57	54.31	45.6	37.08	66.98
Cash & Short-Term Investments	34.71	40.78	75.06	90.18	106.8	133.82
Cash Growth	-41.61%	-45.66%	-16.77%	-15.56%	-20.19%	34.00%
Other Receivables	0.99	0.88	0.99	1	1.13	-
Receivables	0.99	0.88	0.99	1	1.13	-
Prepaid Expenses	0.53	0.99	1.17	1.2	1.48	1.24
Other Current Assets	1.12	1.38	0.21	1.36	2.27	2.8
Total Current Assets	37.35	44.04	77.44	93.75	111.67	137.86
Property, Plant & Equipment	1.08	0.81	0.62	0.68	1.43	1.1
Long-Term Investments	0.08	0.08	0.08	3.58	19.93	50.46
Goodwill	-	-	17.63	-	-	-
Other Intangible Assets	67.57	60.05	63.67	5.9	-	-
Other Long-Term Assets	11.14	9.51	8.47	-	0.19	0.04
Total Assets	117.21	114.48	167.9	103.91	133.23	189.47
Accounts Payable	1.76	2.9	2.03	0.57	4.91	3.56
Accrued Expenses	5.42	3.97	3.12	1.86	8.39	13.16
Current Portion of Leases	0.11	0.1	0.06	0.45	0.74	0.24
Other Current Liabilities	0.18	0.31	4.36	0.19	0.18	0.04
Total Current Liabilities	7.47	7.28	9.57	3.07	14.22	17
Long-Term Debt	16.99	14.32	13.43	-	-	-
Long-Term Leases	0.39	0.39	0.32	-	0.42	0.21
Long-Term Deferred Tax Liabilities	5.6	4.96	5.3	0.25	-	-
Other Long-Term Liabilities	75.04	57.38	54.19	-	-	-
Total Liabilities	105.47	84.33	82.82	3.32	14.64	17.2
Common Stock	0.05	0.04	0.04	0.04	0.03	0.03
Additional Paid-In Capital	413.08	406.61	401.64	389.11	355.23	318.57
Retained Earnings	-407.55	-376.47	-319.64	-288.26	-236.6	-146.65
Comprehensive Income & Other	6.16	-0.04	3.05	-0.29	-0.08	0.31
Total Common Equity	11.74	30.15	85.08	100.59	118.59	172.26
Shareholders' Equity	11.74	30.15	85.08	100.59	118.59	172.26
Total Liabilities & Equity	117.21	114.48	167.9	103.91	133.23	189.47
Total Debt	17.49	14.81	13.81	0.45	1.16	0.45
Net Cash (Debt)	17.22	25.97	61.25	89.73	105.64	133.37
Net Cash Growth	-61.79%	-57.59%	-31.74%	-15.06%	-20.79%	33.56%
Net Cash Per Share	0.39	0.60	1.64	2.68	3.55	4.57
Filing Date Shares Outstanding	53.71	44	43.22	36.28	30.15	29.55
Total Common Shares Outstanding	53.62	44	42.97	36.14	30.07	29.54
Working Capital	29.88	36.76	67.87	90.68	97.45	120.87
Book Value Per Share	0.22	0.69	1.98	2.78	3.94	5.83
Tangible Book Value	-55.83	-29.9	3.79	94.69	118.59	172.26
Tangible Book Value Per Share	-1.04	-0.68	0.09	2.62	3.94	5.83
Machinery	1.28	0.89	0.68	0.43	0.61	0.46
Leasehold Improvements	0.04	0.03	0.04	0.02	0.06	0.02

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q